X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
breast cancer (11) 11
invasiveness (11) 11
cancer (10) 10
expression (10) 10
pathology (10) 10
erbb-2 protein (9) 9
index medicus (8) 8
progression (7) 7
prognosis (6) 6
tumors (6) 6
analysis (5) 5
breast (5) 5
dcis (5) 5
local recurrence (5) 5
oncology (5) 5
adult (4) 4
aged (4) 4
breast carcinoma (4) 4
breast neoplasms - pathology (4) 4
carcinoma, ductal (4) 4
female (4) 4
humans (4) 4
immune microenvironment (4) 4
immunohistochemistry (4) 4
middle aged (4) 4
nottingham breast cancer research centre (4) 4
tumor microenvironment (4) 4
breast neoplasms - mortality (3) 3
cell biology (3) 3
conserving surgery (3) 3
disease-free survival (3) 3
hypoxia (3) 3
lymphocytes (3) 3
radiation therapy (3) 3
risk (3) 3
risk groups (3) 3
stroma (3) 3
aggressive behavior (2) 2
breast neoplasms - immunology (2) 2
carcinoma, intraductal, noninfiltrating - immunology (2) 2
carcinoma, intraductal, noninfiltrating - mortality (2) 2
carcinoma, intraductal, noninfiltrating - pathology (2) 2
cell proliferation (2) 2
cells (2) 2
collagen (2) 2
development and progression (2) 2
dna microarrays (2) 2
ductal carcinoma in situ (2) 2
extracellular matrix (2) 2
features (2) 2
grade (2) 2
in-situ (2) 2
index (2) 2
lymphocytes, tumor-infiltrating - immunology (2) 2
lymphocytes, tumor-infiltrating - pathology (2) 2
medical prognosis (2) 2
menopause (2) 2
metastases (2) 2
microenvironment (2) 2
mrna (2) 2
multivariate analysis (2) 2
neoplasms. tumors. oncology. including cancer and carcinogens (2) 2
nomogram (2) 2
protein expression (2) 2
proteolysis (2) 2
radiotherapy (2) 2
receptor (2) 2
research (2) 2
risk factors (2) 2
surgery (2) 2
survival (2) 2
survival analysis (2) 2
tumor cells (2) 2
aggregates (1) 1
american society (1) 1
amino acids (1) 1
amplification (1) 1
apoptosis (1) 1
atypical ductal hyperplasia (1) 1
automated image analysis (1) 1
b cells (1) 1
b lymphocytes (1) 1
b-lymphocytes - immunology (1) 1
b-lymphocytes - pathology (1) 1
basal (1) 1
base excision-repair (1) 1
basement membrane (1) 1
benign (1) 1
benign breast disease (1) 1
bioindicators (1) 1
biomarker (1) 1
biomarkers (1) 1
biomarkers, tumor - analysis (1) 1
biomarkers, tumor - genetics (1) 1
breast cancer progression (1) 1
breast neoplasms - genetics (1) 1
breast neoplasms - therapy (1) 1
breast-carcinoma (1) 1
c-myc (1) 1
cancer stem cell (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Modern Pathology, ISSN 0893-3952, 12/2018, Volume 31, Issue 12, pp. 1807 - 1815
Current clinicopathological parameters are useful predictors of breast ductal carcinoma in situ behavior, but they are insufficient to define high-risk... 
SYSTEM | APOPTOSIS | DCIS | GROWTH | TXNIP | PROLIFERATION | PATHOLOGY | SUPPRESSION | STRESS | EXPRESSION | CANCER | Immunohistochemistry | Oxidative stress | DNA microarrays | Risk groups | Invasiveness | Estrogen receptors | Tumor suppressor genes | Thioredoxin | Health risk assessment | ErbB-2 protein | Tumors
Journal Article
Modern Pathology, ISSN 0893-3952, 2018, Volume 32, Issue 5, pp. 639 - 649
Legumain is a proteolytic enzyme that plays a role in the regulation of cell proliferation in invasive breast cancer. Studies evaluating its role in ductal... 
IMMUNE MICROENVIRONMENT | NUYS PROGNOSTIC INDEX | LOCAL RECURRENCE | CONSERVING SURGERY | DCIS | RISK | PATHOLOGY | CANCER | EXPRESSION | NOMOGRAM | TUMOR MICROENVIRONMENT | Cell proliferation | Risk groups | Tumor cells | Legumain | Proteolysis | Invasiveness | Stroma | Mastectomy | Breast cancer | Immunoreactivity | ErbB-2 protein | Risk factors
Journal Article
British Journal of Cancer, ISSN 0007-0920, 12/2018, Volume 119, Issue 12, pp. 1518 - 1526
Extracellular matrix (ECM) plays a crucial role in tumour behaviour. Prolyl-4-hydroxlase-A2 (P4HA2) is a key enzyme in ECM remodelling. This study aims to... 
Phenotypes | Carcinoma | Invasiveness | Hydroxylase | Stroma | Extracellular matrix | Breast cancer | Radiation therapy | ErbB-2 protein | Tumors | Necrosis
Journal Article
British Journal of Cancer, ISSN 0007-0920, 05/2019, Volume 120, Issue 11, pp. 1075 - 1082
Previous studies have reported up to 50% of ductal carcinoma in situ (DCIS), is HER2 positive, but the frequency of HER2-positive invasive breast cancer (IBC)... 
Amplification | Immunohistochemistry | Gene amplification | Overexpression | DNA microarrays | Invasiveness | Breast cancer | Hybridization | Gene expression | Multivariate analysis | ErbB-2 protein
Journal Article
BREAST CANCER RESEARCH, ISSN 1465-5411, 07/2019, Volume 21, Issue 1, pp. 83 - 19
BackgroundBreast ductal carcinoma in situ (DCIS) represent approximately 20% of screen-detected breast cancers. The overall risk for DCIS patients treated with... 
SURVIVAL | DIAGNOSIS | Biomarker | BREAST-CARCINOMA | Prognosis | COMPUTATIONAL PATHOLOGY | MARKERS | CANCER | FEATURES | Recurrence prediction | FINE-NEEDLE-ASPIRATION | LOCAL RECURRENCE | ONCOLOGY | Digital image analysis | DCIS | Machine learning | GRADE
Journal Article
Modern Pathology, ISSN 0893-3952, 2019, Volume 32, Issue 10, pp. 1460 - 1472
Journal Article
Modern Pathology, ISSN 0893-3952, 2019, Volume 32, Issue 10, pp. 1473 - 1485
Collagen plays a key role in normal and malignant tissue homeostasis. While the prognostic significance of collagen fiber remodeling in invasive breast cancer... 
IMMUNE MICROENVIRONMENT | LOCAL RECURRENCE | CONSERVING SURGERY | RISK | RADIOTHERAPY | PATHOLOGY | CANCER | EXPRESSION | NOMOGRAM | TUMOR MICROENVIRONMENT | PROGRESSION | Disease resistance | Image processing | Risk groups | Invasiveness | Collagen | Menopause | Homeostasis | Hypoxia | Breast cancer | Radiation therapy | ErbB-2 protein
Journal Article
Journal of clinical pathology, ISSN 0021-9746, 08/2019, p. jclinpath-2019-205939
Cathepsin V (CTSV/CTSL2) is a lysosomal cysteine proteinase and plays a role in extracellular matrix degradation. It is associated with poor prognosis in... 
Journal Article
Histopathology, ISSN 0309-0167, 06/2019, Volume 74, Issue 7, pp. 1025 - 1035
Aims Cathepsin A (CTSA) is a key regulatory enzyme for galactoside metabolism. Additionally, it has a distinct proteolytic activity and plays a role in tumour... 
CTSA | proteolytic | Recurrence | DCIS | TUMOR | RISK | PATHOLOGY | CANCER | CELL BIOLOGY | THERAPY | LOCAL RECURRENCE | MICROENVIRONMENT | INHIBITORS | EXPRESSION | PROGRESSION | Lumpectomy | Physiological aspects | Carcinoma, Ductal | Enzymes | RNA | Analysis | Aggressive behavior | Invasiveness | mRNA | Carboxypeptidase C | ErbB-2 protein | Breast carcinoma | Survival analysis | Proteolysis | Medical prognosis | Surgery | Breast | Hypoxia | Tumors
Journal Article
Histopathology, ISSN 0309-0167, 08/2017, Volume 71, Issue 2, pp. 258 - 268
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 4/2019, Volume 174, Issue 2, pp. 387 - 399
CD133/ prominin 1 is a cancer stem cell marker associated with cancer progression and patient outcome in a variety of solid tumours, but its role in invasive... 
Invasive breast cancer | Oncology | Prognosis | Medicine & Public Health | Cancer Stem Cell | CD133 | SURVIVAL | ONCOLOGY | RECEPTOR | EXPRESSION | CD44 | BASAL
Journal Article